Acumen Pharmaceuticals, Inc.
ABOS- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001576885
No open-market purchases or sales by Acumen Pharmaceuticals, Inc. insiders were filed in the last 90 days; 96 institutions reported holding it in 13F filings for Q2 2026, worth $127.8M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Acumen Pharmaceuticals, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Of which not filed for Q4 2023 | Q4 2023 | Change |
|---|---|---|---|---|
| Holders | 66 | 1 | 67 | +2 |
| Shares | 43.2M | 478.8K | 38.4M | −4.27M (−10.0%) |
| Value | $179.2M | $1.99M | $147.6M | −$29.6M (−16.7%) |
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (20)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pathstone Holdings, LLC | 479,149 | $1.84M | 0.01% |
| Tang Capital Management LLC | 246,895 | $948.1K | 0.09% |
| Man Group plc | 144,630 | $555.4K | 0.00% |
| D. E. Shaw & Co., Inc. | 138,029 | $530.0K | 0.00% |
| Acadian Asset Management LLC | 91,496 | $350.0K | 0.00% |
| 683 Capital Management, LLC | 78,431 | $301.2K | 0.03% |
| Squarepoint Ops LLC | 52,829 | $202.9K | 0.00% |
| Cubist Systematic Strategies, LLC | 33,905 | $130.2K | 0.00% |
| ExodusPoint Capital Management, LP | 32,256 | $124.0K | 0.00% |
| Prelude Capital Management, LLC | 29,100 | $111.7K | 0.01% |
| Virtu Financial LLC | 23,787 | $91.0K | 0.01% |
| Susquehanna Portfolio Strategies, LLC | 21,903 | $84.1K | 0.00% |
| Balyasny Asset Management LLC | 20,578 | $79.0K | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 19,348 | $74.3K | 0.01% |
| Occudo Quantitative Strategies LP | 16,929 | $65.0K | 0.01% |
| Stifel Financial Corp | 16,150 | $62.0K | 0.00% |
| Group One Trading, L.P. | 7,543 | $29.0K | 0.00% |
| Point72 Asia (Singapore) Pte. Ltd. | 2,000 | $7.68K | 0.00% |
| Global Retirement Partners, LLC | 2,000 | $7.26K | 0.00% |
| Advisory Services Network, LLC | 1,000 | $3.84K | 0.00% |
Sold out (18)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Deep Track Capital, LP | 2,513,044 | $10.4M |
| Boxer Capital, LLC | 2,206,983 | $9.16M |
| Great Point Partners LLC | 1,074,101 | $4.46M |
| Altium Capital Management LP | 650,000 | $2.70M |
| Ghost Tree Capital, LLC | 150,000 | $622.5K |
| Bridgeway Capital Management, LLC | 115,033 | $477.4K |
| Wellington Management Group LLP | 104,359 | $433.1K |
| Renaissance Technologies LLC | 87,400 | $363.0K |
| UBS Oconnor LLC | 69,538 | $288.6K |
| DekaBank Deutsche Girozentrale | 40,000 | $167.0K |
| Marshall Wace, LLP | 25,492 | $105.8K |
| Verition Fund Management LLC | 23,500 | $97.5K |
| Pinnacle Associates Ltd | 18,020 | $74.8K |
| Pinnacle Wealth Management Advisory Group, LLC | 18,020 | $74.8K |
| XTX Topco Ltd | 16,538 | $68.6K |
| China Universal Asset Management Co., Ltd. | 1,481 | $6.15K |
| FMR LLC | 657 | $2.73K |
| Daiwa Securities Group Inc. | 165 | $1.00K |
Not filed for Q4 2023 yet (1)
Institutions that held Acumen Pharmaceuticals, Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2023 | Value, Q3 2023 |
|---|---|---|
| Pathstone Family Office, LLC | 478,790 | $1.99M |